| abstract |
The present invention relates to medicine, specifically immunology and gastroenterology. In particular, the present invention relates to probiotic bacteria and extracts thereof for therapeutic use for the treatment of inflammatory diseases such as inflammatory bowel disease. Fecalalibacterium prausnitzi strain HTF-F (DSM26943) or its extract containing extracellular polymeric matrix (EPM) as active ingredients, acceptable carriers, excipients or additives And a composition comprising: Also provided are anti-inflammatory compositions comprising EMP extracted from Fecalibabacterium prausnitzi strain HTF-F and methods for preparing the compositions. [Selection figure] None |